BRXUX
Price
$20.20
Change
+$0.20 (+1.00%)
Updated
Jun 12 closing price
Net Assets
5.01B
VFWPX
Price
$174.75
Change
+$1.20 (+0.69%)
Updated
Jun 12 closing price
Net Assets
94.42B
Interact to see
Advertisement

BRXUX vs VFWPX

Header iconBRXUX vs VFWPX Comparison
Open Charts BRXUX vs VFWPXBanner chart's image
BRXUX vs VFWPX Comparison Chart in %
View a ticker or compare two or three
VS
BRXUX vs. VFWPX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXUX is a Buy and VFWPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFWPX has more cash in the bank: 94.4B vs. BRXUX (5.01B). VFWPX pays higher dividends than BRXUX: VFWPX (2.62) vs BRXUX (1.36). BRXUX was incepted earlier than VFWPX: BRXUX (11 years) vs VFWPX (16 years). BRXUX (0.53) is less costly to investors than VFWPX (0.03). BRXUX is a more actively managed with annual turnover of: 48.00 vs. VFWPX (6.00). BRXUX has a lower initial minimum investment than VFWPX: BRXUX (0) vs VFWPX (100000000). BRXUX annual gain was more profitable for investors over the last year : 32.15 vs. VFWPX (26.05). BRXUX return over 5 years is better than : 63.73 vs. VFWPX (33.90).
BRXUXVFWPXBRXUX / VFWPX
Total Expense Ratio0.520.031,733%
Annual Report Gross Expense Ratio0.530.031,767%
Fund Existence11 years16 years-
Gain YTD16.42713.944118%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.01B94.4B5%
Annual Yield % from dividends1.362.6252%
Returns for 1 year32.1526.05123%
Returns for 3 years82.5555.80148%
Returns for 5 years63.7333.90188%
Returns for 10 years174.53116.07150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLED91.461.58
+1.76%
Universal Display Corp
NBBK20.620.18
+0.88%
NB Bancorp
EQ2.81N/A
N/A
Equillium
ATER1.20-0.01
-0.83%
Aterian
ALNY282.85-6.54
-2.26%
Alnylam Pharmaceuticals